Axela

Axela, Inc offers a unique portfolio of next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins.

Axela offers a unique portfolio of next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. Our suite of products are specifically targeted at biomarker testing and infectious disease research and designed to facilitate the transition to personalized medicine. They are commercialized through distributors in the Life Sciences and Clinical Research markets, and specific applications are licensed to diagnostic or industry segment partners. Our product line consists of instruments, consumable (sensors, chips and reagents) and applications (biomarker content, methods for analysis and software).